<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-10-22">October 22, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Felix</forename><forename type="middle">C</forename><surname>Giani</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Fiorini</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>, ...,</roleName><forename type="first">Aoi</forename><surname>Wakabayashi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Deborah</forename><forename type="middle">L</forename><surname>French</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kiran</forename><surname>Musunuru</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Stem Cell and Regenerative Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Vijay</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
							<email>sankaran@broadinstitute.org</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leif</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Institute for Chemistry and Biochemistry</orgName>
								<orgName type="institution">Freie Universita ¨t Berlin</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rany</forename><forename type="middle">M</forename><surname>Salem</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Division of Endocrinology and Center for Basic and Translational Obesity Research</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chintan</forename><forename type="middle">D</forename><surname>Jobaliya</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><forename type="middle">N</forename><surname>Regan</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Stem Cell and Regenerative Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacob</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ge</forename><surname>Liang</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Orna</forename><surname>Steinberg-Shemer</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><forename type="middle">H</forename><surname>Guo</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Division of Endocrinology and Center for Basic and Translational Obesity Research</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">To</forename><surname>˜nu Esko</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Division of Endocrinology and Center for Basic and Translational Obesity Research</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wei</forename><surname>Tong</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carlo</forename><surname>Brugnara</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Laboratory Medicine</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joel</forename><forename type="middle">N</forename><surname>Hirschhorn</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Division of Endocrinology and Center for Basic and Translational Obesity Research</orgName>
								<orgName type="institution" key="instit1">Boston Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mitchell</forename><forename type="middle">J</forename><surname>Weiss</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Hematology</orgName>
								<orgName type="institution">St. Jude Children&apos;s Research Hospital</orgName>
								<address>
									<postCode>38105</postCode>
									<settlement>Memphis</settlement>
									<region>TN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leonard</forename><forename type="middle">I</forename><surname>Zon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep3">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">Broad Institute of MIT and Harvard</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Stem Cell and Regenerative Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stella</forename><forename type="middle">T</forename><surname>Chou</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Departments of Pathology and Laboratory Medicine and Pediatrics</orgName>
								<orgName type="institution" key="instit1">The Children&apos;s Hospital of Philadelphia</orgName>
								<orgName type="institution" key="instit2">University of Pennsylvania</orgName>
								<address>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-10-22">October 22, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">EECD53291721698B694EB1B2B76411AE</idno>
					<idno type="DOI">10.1016/j.stem.2015.09.015</idno>
					<note type="submission">Received: April 22, 2015 Revised: July 11, 2015 Accepted: September 20, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Highlights d Genetic mutations in SH2B3 associate with higher hemoglobin levels in humans d Suppression of SH2B3 in HSPCs improves erythroid expansion and differentiation d SH2B3 suppression does not impair the production of fully mature RBCs d SH2B3 inactivation by genome editing in PSCs increases erythroid expansion</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>sources for cell and tissue replacement therapies.</s><s>For example, stem cell-derived red blood cells (RBCs) are a potential alternative to donated blood, but yield and quality remain a challenge.</s><s>Here, we show that application of insight from human population genetic studies can enhance RBC production from stem cells.</s><s>The SH2B3 gene encodes a negative regulator of cytokine signaling and naturally occurring loss-of-function variants in this gene increase RBC counts in vivo.</s><s>Targeted suppression of SH2B3 in primary human hematopoietic stem and progenitor cells enhanced the maturation and overall yield of in-vitroderived RBCs.</s><s>Moreover, inactivation of SH2B3 by CRISPR/Cas9 genome editing in human pluripotent stem cells allowed enhanced erythroid cell expansion with preserved differentiation.</s><s>Our findings therefore highlight the potential for combining human genome variation studies with genome editing approaches to improve cell and tissue production for regenerative medicine.</s></p><p><s>There is significant excitement regarding the use of stem cells as a source for cell replacement therapies <ref type="bibr" target="#b8">(Fox et al., 2014)</ref>.</s><s>In vitro differentiated red blood cells (RBCs) from hematopoietic stem and progenitor cells (HSPCs) have been successfully transfused into recipients in clinical trials <ref type="bibr" target="#b10">(Giarratana et al., 2011;</ref><ref type="bibr" target="#b23">Migliaccio et al., 2012)</ref>, and similar approaches using pluripotent stem cells (PSCs), including human embryonic stem cells (hESCs) and induced PSCs (iPSCs), are under investigation <ref type="bibr" target="#b17">(Kobari et al., 2012;</ref><ref type="bibr" target="#b32">Slukvin, 2013;</ref><ref type="bibr" target="#b34">Sturgeon et al., 2013)</ref>.</s><s>However, utilizing these stem cell sources for RBC production is limited by low yields of fully mature cells, making the process costly and inefficient <ref type="bibr" target="#b23">(Migliaccio et al., 2012;</ref><ref type="bibr" target="#b28">Rousseau et al., 2014)</ref>.</s><s>Overcoming these major limitations could enhance our ability to manage the blood supply <ref type="bibr" target="#b39">(Williamson and Devine, 2013)</ref>.</s></p><p><s>Numerous ongoing efforts focus on optimizing culture methods to improve RBC production from various stem cell sources <ref type="bibr" target="#b15">(Huang et al., 2015;</ref><ref type="bibr" target="#b28">Rousseau et al., 2014)</ref>.</s><s>A complementary approach is to investigate whether human genes that regulate RBC production in vivo can be manipulated to enhance this process in vitro.</s><s>Recent genome-wide association studies (GWASs) of RBC traits and subsequent fine-mapping identified a common coding single nucleotide polymorphism (SNP) in the SH2B3 gene (rs3184504), which results in a R262W substitution, that is significantly associated with hemoglobin levels and RBC counts in vivo <ref type="bibr" target="#b36">(van der Harst et al., 2012)</ref>.</s><s>SH2B3 is an SH2and PH-domain-containing protein that negatively regulates hematopoietic cytokine signaling.</s><s>Mice with null mutations in SH2B3 have normal hemoglobin and RBC counts, suggesting human-specific functions in RBC production (erythropoiesis) <ref type="bibr" target="#b3">(Bersenev et al., 2008;</ref><ref type="bibr" target="#b37">Velazquez et al., 2002)</ref>.</s><s>The rs3184504 variant associated with increased RBC counts and hemoglobin levels is thought to be a hypomorphic allele <ref type="bibr" target="#b22">(McMullin et al., 2011;</ref><ref type="bibr" target="#b36">van der Harst et al., 2012)</ref>.</s><s>Consistent with this possibility, rare loss-of-function (LoF) SH2B3 alleles are associated with greater elevations in the RBC count and hemoglobin level (erythrocytosis) <ref type="bibr" target="#b19">(Lasho et al., 2010;</ref><ref type="bibr" target="#b33">Spolverini et al., 2013)</ref>.</s><s>To extend this observation to a population-based cohort, we examined a group of 4,678 individuals subjected to whole-exome sequencing and observed higher hemoglobin/hematocrit values among individuals with rare putative damaging missense or LoF variants in SH2B3 (Figures <ref type="figure" target="#fig_0">1A and 1B</ref>, Tables <ref type="table">S1  and S2</ref>).</s></p><p><s>Given the association between elevated hemoglobin levels and LoF alleles of SH2B3 in human population genetic studies, we tested whether suppression of SH2B3 can enhance erythropoiesis in vitro.</s><s>We used lentiviral vectors to express short hairpin RNAs (shRNAs) targeting SH2B3 in adult CD34 + HSPCs that were induced to undergo erythroid differentiation (Figures <ref type="figure" target="#fig_0">1C and 1D</ref>).</s><s>The SH2B3 LoF cultures differentiated similar to controls, although the erythroid maturation as determined by cell surface phenotyping (loss of CD71, as well as acquisition of CD235a) occurred earlier (Figures <ref type="figure" target="#fig_0">1E and  1F</ref>).</s><s>Interestingly, we noticed a 1.6-to 2-fold increase in enucleation in SH2B3 LoF erythroblasts (Figure <ref type="figure" target="#fig_0">1G</ref>).</s><s>These observations were confirmed by analysis of cell morphology that demonstrated improved maturation, better hemoglobinization, and greater enucleation (Figure <ref type="figure" target="#fig_0">1H</ref>).</s><s>Gene expression analysis of erythroblasts from the SH2B3 LoF cultures showed a globally similar profile with those of controls (Figure <ref type="figure" target="#fig_0">1I</ref>), with enhanced expression of genes associated with terminal erythroid maturation (Figure <ref type="figure" target="#fig_0">1J</ref>).</s><s>We maintained the cultures following enucleation for several days and did not observe any improvement in maturation in the controls in comparison with the SH2B3 LoF cultures.</s></p><p><s>Since cells with SH2B3 LoF appeared to undergo erythroid differentiation more readily, we wondered if their proliferative potential was restrained, which could compromise RBC yield.</s><s>Surprisingly, adult HSPCs with SH2B3 LoF expanded to a significantly greater extent when compared with controls (Figure <ref type="figure">2A</ref>, Figure <ref type="figure" target="#fig_0">S1A</ref>).</s><s>The overall increase in expansion occurred over multiple stages of the differentiation process, suggesting that SH2B3 suppression augments multiple signaling pathways at different stages of differentiation (Figure <ref type="figure" target="#fig_0">S1A</ref>).</s><s>The observed effect was not due to suboptimal cytokine concentrations, as the cells were cultured in erythropoietin (EPO) and other cytokine concentrations where they demonstrated maximal expansion (Figure <ref type="figure" target="#fig_0">S1B</ref>) <ref type="bibr" target="#b2">(Abkowitz et al., 1991)</ref>.</s><s>Overall, the yield of mature RBCs was expanded 3-to 5-fold by suppression of SH2B3 (Figure <ref type="figure">2A</ref>).</s><s>We performed a similar knockdown of SH2B3 in CD34 + cord blood HSPCs, which are known to exhibit over 10-fold greater expansion during erythroid differentiation compared to adult HSPCs <ref type="bibr" target="#b10">(Giarratana et al., 2011;</ref><ref type="bibr" target="#b23">Migliaccio et al., 2012;</ref><ref type="bibr" target="#b28">Rousseau et al., 2014)</ref>.</s><s>In these cultures, SH2B3 LoF further enhanced enucleated RBC yield by 2-to 4-fold (Figure <ref type="figure">2B</ref>).</s><s>In addition, we also utilized an adaptation of a recently described culture approach incorporating a progenitor expansion step with adult CD34 + HSPCs <ref type="bibr" target="#b20">(Lee et al., 2015;</ref><ref type="bibr" target="#b21">Ludwig et al., 2014;</ref><ref type="bibr" target="#b29">Sankaran et al., 2011)</ref>.</s><s>In this case, we noted an even greater increase in expansion and overall yield of RBCs of 5-to 7-fold (Figure <ref type="figure">2C</ref>), demonstrating the generalizability of SH2B3 suppression to augment RBC production from HSPCs.</s></p><p><s>We then wanted to understand the mechanisms through which suppression of SH2B3 is able to augment erythroid differentiation and expansion.</s><s>The fraction of apoptotic cells, as assessed by annexin V staining, was not altered by SH2B3 suppression in adult HSPCs (Figure <ref type="figure" target="#fig_0">S1C</ref>).</s><s>Cells with SH2B3 LoF underwent 0.5-1 additional cell divisions over the 4 day period of differentiation examined (Figures <ref type="figure" target="#fig_0">S1D and S1E</ref>) <ref type="bibr" target="#b30">(Sankaran et al., 2012)</ref>.</s><s>SH2B3 negatively regulates signaling downstream of multiple cell surface signaling receptors implicated in erythropoiesis, including EPO, KIT, and integrin receptors <ref type="bibr" target="#b9">(Gery and Koeffler, 2013;</ref><ref type="bibr" target="#b22">McMullin et al., 2011)</ref>.</s><s>Accordingly, phosphorylation of STAT5 and KIT receptor and the expression of early EPO responsive genes were enhanced by SH2B3 suppression (Figures S1F and S1G) <ref type="bibr" target="#b26">(Moraga et al., 2015)</ref>.</s><s>We could verify the importance of both the EPO and KIT/SCF pathways for the observed augmentation upon SH2B3 suppression by limiting the concentration of both cytokines in the HSPC differentiation cultures (Figure <ref type="figure" target="#fig_0">S1H</ref>).</s><s>SH2B3 suppression allowed erythroid expansion similar to the baseline control, with reduced levels of either EPO or SCF, highlighting the role of SH2B3 in both pathways in primary erythroid cells.</s><s>Thus, SH2B3 LoF appears to facilitate erythroid expansion and maturation by augmenting both the EPO and KIT signaling pathways.</s></p><p><s>Since production of erythroid cells from human HSPCs appeared to be increased by SH2B3 LoF, we examined whether the RBCs produced in vitro were altered from those of controls.</s><s>The average volume of RBCs was similar between those arising from control and SH2B3 LoF cultures (average of 108.7 in controls, compared with 110.1 and 104.7 femtoliters in the sh83 and sh84 SH2B3 shRNAs).</s><s>These values were within the normal range of 103-126 femtoliters for reticulocytes (immature RBCs, equivalent to those produced in the culture) found in human adults <ref type="bibr" target="#b4">(d'Onofrio et al., 1995)</ref>.</s><s>Moreover, SH2B3 LoF improved hemoglobinization with the mean hemoglobin content being 27 and 26.7 picograms (pg) in sh83-and sh84-treated cells, respectively, compared with 25.4 in controls (human adult reticulocytes generally have concentrations of 25.9-30.6</s><s>pg; d <ref type="bibr">'Onofrio et al., 1995)</ref>.</s><s>Disorders of the RBC membrane, such as hereditary spherocytosis, are clinically diagnosed by variation in binding of the dye eosin-5-maleimide (EMA) <ref type="bibr" target="#b27">(Perrotta et al., 2008)</ref>.</s><s>We found that EMA staining was comparable between the SH2B3 LoF RBCs and controls, suggesting normal formation of the RBC cytoskeleton (Figure <ref type="figure">2D</ref>).</s><s>In addition, surface expression of RBC antigens, including the Rh blood group (Figure <ref type="figure">S2A</ref>) and CD44, and activity of the cytoplasmic pyruvate kinase enzyme were similar between the SH2B3 LoF RBCs and controls (Figure <ref type="figure">S2B</ref>).</s><s>RBC ghosts from the SH2B3 LoF and control cells showed identical protein patterns, providing an independent metric for normal RBC maturation (Figure <ref type="figure">S2C</ref>).</s><s>We also observed normal hemoglobin subunits present in the RBCs with a small increase in fetal hemoglobin (HbF) production with SH2B3 LoF, consistent with the known increase in HbF observed with acceleration at the early stages of erythropoiesis (Figure <ref type="figure">S2D</ref>) <ref type="bibr" target="#b29">(Sankaran and Orkin, 2013)</ref>.</s><s>Collectively, these results suggest that RBC physiology was not impaired in cells derived from SH2B3 LoF HSPCs, despite a marked improvement in differentiation and expansion.</s></p><p><s>Overall, our results suggest that reducing SH2B3 expression could improve in vitro production of RBCs for transfusion purposes.</s><s>While viral-mediated shRNA delivery to primary CD34 + HSPCs may be impractical on a large scale, it should be possible to disrupt the SH2B3 gene in self-renewing cell lines that can be used for RBC production <ref type="bibr" target="#b28">(Rousseau et al., 2014)</ref>.</s><s>Despite promising recent advances <ref type="bibr" target="#b12">(Hirose et al., 2013;</ref><ref type="bibr" target="#b14">Huang et al., 2014;</ref><ref type="bibr" target="#b18">Kurita et al., 2013)</ref>, no immortalized human cell lines allow consistent differentiation into mature RBCs.</s><s>However, PSCs can be readily differentiated toward the erythroid lineage with well-established protocols <ref type="bibr" target="#b15">(Huang et al., 2015;</ref><ref type="bibr" target="#b17">Kobari et al., 2012;</ref><ref type="bibr" target="#b24">Mills et al., 2014;</ref><ref type="bibr" target="#b32">Slukvin, 2013;</ref><ref type="bibr" target="#b35">Sturgeon et al., 2014)</ref> (Figure <ref type="figure">2E</ref>).</s><s>We used CRISPR/Cas9-mediated genome editing to engineer isogenic hESC lines with either homozygous frameshift deletions in SH2B3 or intact WT alleles (Figures <ref type="figure">S2E and  S2F</ref>) <ref type="bibr" target="#b5">(Ding et al., 2013a</ref><ref type="bibr" target="#b7">(Ding et al., , 2013b;;</ref><ref type="bibr" target="#b11">Gupta and Musunuru, 2014;</ref><ref type="bibr" target="#b38">Veres et al., 2014)</ref>.</s><s>The hESCs were differentiated in vitro to generate multipotent hematopoietic progenitor cells (HPCs) with erythroid, megakaryocytic, and myeloid potential (Kennedy  <ref type="bibr">, 2012;</ref><ref type="bibr" target="#b24">Mills et al., 2014;</ref><ref type="bibr" target="#b34">Sturgeon et al., 2013)</ref> (Figure <ref type="figure">2E</ref>).</s><s>No differences in the yield of multipotent CD41a + /CD235a + HPCs were noted between differentiating WT and SH2B3 knockout hESCs <ref type="bibr" target="#b24">(Mills et al., 2014)</ref>.</s><s>However, in multiple independent isogenic hESC lines studied, loss of SH2B3 augmented erythroid cell production more than 3-fold (Figures <ref type="figure">2F and 2G</ref>, Figure <ref type="figure">S2G</ref>).</s><s>Importantly, maturing WT and SH2B3 knockout erythroblasts exhibited similar morphologies, expression of erythroid cell surface markers, and globin gene expression patterns (Figures <ref type="figure">2H and 2I</ref>, Figure <ref type="figure">S2H</ref>).</s><s>While PSC erythroid differentiation protocols continue to undergo refinement, are not yet optimized for RBC manufacture, and primarily produce the earliest waves of hematopoiesis equivalent to those that developmentally arise from the yolk sac <ref type="bibr" target="#b17">(Kobari et al., 2012;</ref><ref type="bibr" target="#b32">Slukvin, 2013;</ref><ref type="bibr" target="#b35">Sturgeon et al., 2014)</ref>, the current findings provide a proof of principle that stable perturbation of SH2B3 can allow for improved erythroid differentiation and expansion.</s></p><p><s>It is estimated that a unit of RBCs produced from HSPCs would cost $8,000-$15,000 using current in vitro differentiation protocols, while normal donor-derived units cost less than one-tenth of this amount <ref type="bibr" target="#b23">(Migliaccio et al., 2012;</ref><ref type="bibr" target="#b28">Rousseau et al., 2014)</ref>.</s><s>While improvements in culture methods and use of systems such as bioreactors may be extremely valuable to improve upon this process, intrinsic alteration of stem cell sources to stimulate erythropoiesis should optimize the process further.</s><s>To the best of our knowledge this has not been previously tested.</s><s>Here we show that by utilizing observations from both common and rare human genetic variation, we could perturb the SH2B3 gene to improve the ability of stem-cell-derived hematopoietic progenitors to expand and differentiate into the erythroid lineage.</s><s>We would note that the improvement of both expansion and differentiation surpasses the maximal expansion that could normally be achieved by simply optimizing cytokine concentrations in such cultures, which illustrates the complementary benefit of targeting intrinsic regulatory pathways.</s><s>The increase in yields resulting from SH2B3 suppression should allow RBCs to be produced from HSPCs at an estimated cost that is less than one-fifth of current approaches and with fewer starting stem cells.</s><s>Thus, a single RBC unit is estimated to require 25 million CD34 + HSPCs and perturbation of SH2B3 should reduce the required number of starting cells to 5 million <ref type="bibr" target="#b23">(Migliaccio et al., 2012)</ref>.</s><s>With additional technological advances it is likely that both the cost and the efficiency of this process can be improved further.</s><s>Importantly, our studies suggest that perturbation of SH2B3 should improve erythroid differentiation from a variety of human stem cell sources, regardless of the differentiation method employed.</s><s>Nonetheless, hurdles remain to effectively translate these observations to improve and deliver upon the promise of such cell replacement therapies <ref type="bibr" target="#b8">(Fox et al., 2014;</ref><ref type="bibr" target="#b32">Slukvin, 2013)</ref>.</s><s>We envision that future studies on the role of human genetic variation in blood cell traits will further contribute to our ability to manipulate this process for therapeutic purposes and manage the ever-increasing demand on the blood supply <ref type="bibr" target="#b39">(Williamson and Devine, 2013)</ref>.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>From In Vivo Association of SH2B3 Variants with Hemoglobin Levels to In Vitro Suppression in Primary HSPCs (A) A schematic of the protein structure of SH2B3, including the dimerization (Dimer.</s><s>Domain), pleckstrin homology (PH), and Src homology 2 (SH2) domains.</s><s>The amino acids of these different regions are shown below.</s><s>The strict damaging missense variants in the PH/SH2 domains and the nonsense variant identified in the European American individuals analyzed are shown.</s><s>(B) Box plots for hemoglobin levels in the individuals harboring putative damaging missense and nonsense variants in SH2B3 (n = 19) or without such mutations (n = 1995).</s><s>Details of the association parameters from gene burden testing of these rare variants are provided in Table S1.</s><s>(C) Simplified scheme illustrating differentiation of human CD34 + HSPCs into mature RBCs.</s><s>(D) Western blot showing SH2B3 protein levels 8 days following infection.</s><s>(E and F) Representative histogram plots of CD235a and CD71, respectively, showing phenotypic surface marker expression of control and SH2B3-KD cells on the indicated day of differentiation.</s><s>(G) Representative flow cytometry plots showing cells stained with CD235a and Hoechst 33342 on day 18 of differentiation.</s><s>Numbers represent the mean percentage of CD235a + /Hoechst 33342cells, indicative of enucleated RBCs, within the depicted gate ± SD. (H) Representative cytocentrifuge images of May-Gru ¨nwald-Giemsa stained control and SH2B3-KD cells at the indicated days of differentiation.</s><s>A scale bar is shown in upper left panel.</s><s>(I) Scatter plot of mean gene expression values of control (Luc-KD for cells treated with control shLuc) and SH2B3-KD samples (n = 3 independent samples for shLuc, sh83, and sh84).</s><s>The coefficient of determination (r) is shown.</s><s>(J) Enrichment profiles from gene set enrichment analysis comparing the relative expression of genes in SH2B3-KD samples versus control.</s><s>An enrichment plot showing an erythroid differentiation signature derived by comparing early erythroid progenitors with more differentiated cells is shown (p &lt; 0.0001 using a modified Kolmogorov-Smirnov statistical test).</s></p></div></figDesc><graphic coords="3,81.17,238.87,294.32,439.03" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="1,55.16,194.51,285.82,285.68" type="bitmap" /></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACCESSION NUMBERS</head><p><s>The accession number for the gene expression data reported in this paper is Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/):</s><s>GEO: GSE67219.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPPLEMENTAL INFORMATION</head><p><s>Supplemental Information for this article includes two figures, two tables, and Supplemental Experimental Procedures and can be found with this article online at http://dx.doi.org/10.1016/j.stem.2015.09.015.</s><s>(C) Mean yield of enucleated RBCs (CD235a + /Hoechst 33342 -) observed for control and SH2B3 KD samples derived from adult mobilized peripheral blood progenitors using a more efficient differentiation protocol involving a CD34 + expansion phase (discussed in the Supplemental Experimental Procedures).</s><s>Comparisons were done by a two-tailed Student's t test (n = 4; ***p &lt; 0.001).</s><s>(D) Representative histogram plots showing eosin-5-maleimide signal on day 18 of mature RBCs derived from peripheral-blood-mobilized CD34 + cells.</s><s>See also Figure <ref type="figure">S2</ref>.</s><s>(E) Simplified scheme illustrating differentiation of hESCs into RBCs.</s><s>The hESCs were cultured in sequential cytokine combinations to induce the production of multipotent hematopoietic progenitor cells (HPCs) that were released into the medium around day 8.</s><s>The HPCs were collected and cultured further in medium with EPO and SCF to support erythroid differentiation.</s><s>(F and G) Erythroid cell expansion of HPCs derived from two independent pairs of isogenic hESC clones (KO, SH2B3-knockout; WT, wild-type isogenic controls).</s><s>The total cell numbers starting with 50,000 cells are shown at various time points as the mean ± SD.</s><s>Comparisons were performed by a two-tailed Student's t test (n = 3; *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001; ****p &lt; 0.0001).</s><s>See also Figure <ref type="figure">S2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conceptualization</head><p><s>(H) Representative cytospin images of May-Gru ¨nwald-Giemsa stained control and SH2B3-KO erythroblasts at the indicated days of culture subsequent to HPC selection.</s><s>(I) Representative flow cytometry plots depicting the expression of CD71 and CD235a on erythroblasts derived from SH2B3-KO and isogenic WT hESCs.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">NIH) grants R21 HL120791 and R01 DK103794</title>
		<imprint>
			<biblScope unit="page" from="K99" to="L122515" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename></persName>
		</author>
		<imprint>
			<biblScope unit="page">R01</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Abkowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Sabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Blau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Zsebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Papayannopoulou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="2198" to="2202" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bersenev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Balcerek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="2832" to="2844" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia</title>
		<author>
			<persName><forename type="first">G</forename><surname>Onofrio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chirillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Caenaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tommasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Micciulli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="818" to="823" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Veres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kuperwasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Motola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Meissner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Hendriks</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A TALEN genome-editing system for generating human stem cell-based disease models</title>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="238" to="251" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Regan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Oostrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Cowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Musunuru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="393" to="394" />
			<date type="published" when="2013">2013b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Q</forename><surname>Daley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trucco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page">1247391</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Role of the adaptor protein LNK in normal and malignant hematopoiesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Koeffler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="3111" to="3118" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Proof of principle for transfusion of in vitro-generated red blood cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Giarratana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rouard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dumont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Safeukui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Le Pennec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Franc ¸ois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Trugnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Peyrard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Marie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="5071" to="5079" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Musunuru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="4154" to="4161" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Hirose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nagasawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ochi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hirata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Otsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sano</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells</title>
	</analytic>
	<monogr>
		<title level="j">Stem Cell Reports</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="499" to="508" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Dowey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Mendelsohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Kickler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="451" to="463" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation</title>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mendelsohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1470" to="1479" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Awong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Sturgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ditadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lamotte-Mohs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Zu ´n ˜iga-Pflu ¨cker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Keller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1722" to="1735" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kobari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Oudrhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Francina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kiger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mazurier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rouzbeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>El-Nemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Giarratana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1795" to="1803" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kurita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miharada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hiroyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Miyoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e59890</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">LNK mutations in JAK2 mutation-negative erythrocytosis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Lasho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pardanani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tefferi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="page" from="1189" to="1190" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">PPAR-a and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Barrasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Elmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Lodish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">522</biblScope>
			<biblScope unit="page" from="474" to="477" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Altered translation of GATA1 in Diamond-Blackfan anemia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Gazda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Eichhorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thiru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ghazvinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">I</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gotlib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Beggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sieff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="748" to="753" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Mcmullin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Percy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hematol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="962" to="964" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The potential of stem cells as an in vitro source of red blood cells for transfusion</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Migliaccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Whitsett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Papayannopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadelain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="115" to="119" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Paluru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gadue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>French</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Hematopoietic differentiation of pluripotent stem cells in culture</title>
	</analytic>
	<monogr>
		<title level="j">Methods Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">1185</biblScope>
			<biblScope unit="page" from="181" to="194" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands</title>
		<author>
			<persName><forename type="first">I</forename><surname>Moraga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wernig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wilmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gryshkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fabionar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Wehrman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1196" to="1208" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Hereditary spherocytosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Perrotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Gallagher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mohandas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="1411" to="1426" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Rousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Giarratana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Douay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechnol. J</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="28" to="38" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Menne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vergilio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thiru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Orkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Lodish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="1519" to="1524" />
			<date type="published" when="2011">2013. 2011</date>
		</imprint>
	</monogr>
	<note>The switch from fetal to adult hemoglobin. Cold Spring Harb. Perspect. Med. 3, a011643</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sicinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Metcalf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Natkunam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number</title>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2075" to="2087" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">I</forename><surname>Slukvin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="4035" to="4046" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative &apos;idiopathic&apos; erythrocytosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Spolverini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Guglielmelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pancrazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Paoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nichele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruggeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Vannucchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="e101" to="e102" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Defining the path to hematopoietic stem cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Sturgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ditadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Keller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="416" to="418" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Sturgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ditadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Awong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Keller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="554" to="561" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Seventy-five genetic loci influencing the human red blood cell</title>
		<author>
			<persName><forename type="first">P</forename><surname>Van Der Harst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mateo</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rendon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sehmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Elling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Allayee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">492</biblScope>
			<biblScope unit="page" from="369" to="375" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Velazquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Furlonger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vesely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Paige</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="1599" to="1611" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing</title>
		<author>
			<persName><forename type="first">A</forename><surname>Veres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Gosis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ragavendran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Brand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Erdin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Cowan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Talkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Musunuru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="27" to="30" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Challenges in the management of the blood supply</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Devine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page" from="1866" to="1875" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
